Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Furaprevir - Dongguan HEC TaiGen Biopharmaceuticals

Next Previous
Drug Profile

Furaprevir - Dongguan HEC TaiGen Biopharmaceuticals

Alternative Names: TG-2349

Latest Information Update: 22 Mar 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator TaiGen Biotechnology
  • Developer Dongguan HEC TaiGen Biopharmaceuticals; TaiGen Biotechnology
  • Class Antivirals; Benzofurans; Carbamates; Cyclopentanes; Cyclopropanes; Pyrimidines; Pyrroles
  • Mechanism of Action Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Hepatitis C

Most Recent Events

  • 22 Mar 2022 Furaprevir is still in phase II trials for Hepatitis C in Taiwan and USA (TaiGen Biotechnology pipeline, March 2022)
  • 22 Mar 2022 Furaprevir is still in phase III trials for Hepatitis C in China (TaiGen Biotechnology pipeline, March 2022)
  • 09 Feb 2021 Dongguan HEC TaiGen Biopharmaceuticals completes a phase III trial in Hepatitis C in China (NCT04155515)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top